Literature DB >> 1922060

Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts.

P Dobrazanski1, T Noguchi, K Kovary, C A Rizzo, P S Lazo, R Bravo.   

Abstract

We demonstrate that a member of the fos family, the fosB gene, gives rise to two transcripts by alternative splicing of exon 4, generating two proteins, FosB of 338 amino acids and a short form, FosB/SF, which contains the DNA binding and dimerization domains but not the 101 amino acids of the C terminus. FosB/SF activates an AP-1-chloramphenicol acetyltransferase construct in NIH 3T3 cells, as determined by transient and stable transfections, although more weakly than does FosB. In contrast to FosB, FosB/SF has lost its ability to repress the dyad symmetry element of the c-fos gene. FosB/SF when expressed in excess to FosB can downmodulate the activity of FosB. Constitutive expression of high levels of FosB/SF in NIH 3T3 cells has no significant inhibitory effect in the induction of cell proliferation or cell cycle progression, indicating that FosB/SF is not a negative regulator of cell growth. This conclusion is further confirmed by the observation that the majority of the Jun molecules are complexed with FosB/SF in the FosB/SF-overexpressing cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922060      PMCID: PMC361916          DOI: 10.1128/mcb.11.11.5470-5478.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  51 in total

1.  Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences.

Authors:  R Treisman
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

Review 2.  Dimers, leucine zippers and DNA-binding domains.

Authors:  S J Busch; P Sassone-Corsi
Journal:  Trends Genet       Date:  1990-02       Impact factor: 11.639

3.  Structure-function analysis of fos protein: a single amino acid change activates the immortalizing potential of v-fos.

Authors:  T Jenuwein; R Müller
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

4.  Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein.

Authors:  W Kruijer; J A Cooper; T Hunter; I M Verma
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

5.  Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.

Authors:  M E Greenberg; E B Ziff
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

6.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation.

Authors:  J T Holt; T V Gopal; A D Moulton; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  29 in total

Review 1.  DeltaFosB: a sustained molecular switch for addiction.

Authors:  E J Nestler; M Barrot; D W Self
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

2.  Control of excision frequency of maize transposable element Ds in Petunia protoplasts.

Authors:  D Becker; R Lütticke; M Li; P Starlinger
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  Absence of a persistently elevated 37 kDa fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice.

Authors:  A Mandelzys; M A Gruda; R Bravo; J I Morgan
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

Review 4.  Review. Transcriptional mechanisms of addiction: role of DeltaFosB.

Authors:  Eric J Nestler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-10-12       Impact factor: 6.237

5.  Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures.

Authors:  N Hiroi; G J Marek; J R Brown; H Ye; F Saudou; V A Vaidya; R S Duman; M E Greenberg; E J Nestler
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

6.  RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanism.

Authors:  F B Furnari; V Zacny; E B Quinlivan; S Kenney; J S Pagano
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Proliferative activation of quiescent Rat-1A cells by delta FosB.

Authors:  Y Nakabeppu; S Oda; M Sekiguchi
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

8.  Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior.

Authors:  François Frenois; Maïté Moreau; Jason O'Connor; Marc Lawson; Charlotte Micon; Jacques Lestage; Keith W Kelley; Robert Dantzer; Nathalie Castanon
Journal:  Psychoneuroendocrinology       Date:  2007-05-04       Impact factor: 4.905

9.  TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.

Authors:  Cachétne S X Barrett; Ana C Millena; Shafiq A Khan
Journal:  Prostate       Date:  2016-09-07       Impact factor: 4.104

10.  Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.

Authors:  K L Hawker; A Pintzas; R F Hennigan; D A Gillespie; B W Ozanne
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.